Background: Melioidosis has emerged as a global problem; however, few studies have specifically described the clinical characteristics and outcomes when patients with melioidosis are treated at an emergency department (ED). Purpose: The objective of this study was to examine the demographics and clinical characteristics of patients with melioidosis who visited an ED. Methods: A retrospective analysis of patients treated for melioidosis at an ED. Results: Of the 25 patients identified over 7 years, 22 patients had bacteremia, whereas diabetes mellitus was the most common underlying disease (17 patients). Acute respiratory failure requiring mechanical ventilation developed in 52% of the patients. The overall mortality rate was 40%, and death within 48 hours of presentation at the ED occurred in 24% of the patients. The most common infection site was the lungs (in 52% of patients), and 36% of the patients presented with community-acquired pneumonia (CAP) at the ED. A comparison of the CAP and non-CAP groups of patients revealed that the presence of shock upon arrival (56% vs. 0; p ¼ 0.002), total mortality (78% vs. 19%; p ¼ 0.009), and early mortality (56% vs. 6%; p ¼ 0.012) were significantly more common among the individuals who comprised the CAP group. Early mortality accounted for 60% of total deaths, and all of these patients died before final microbiologic data were available. CAP presentation ( p ¼ 0.012), the presence of band-form leukocytes ( p ¼ 0.001), increased serum creatinine ( p ¼ 0.037), and shock on arrival ( p ¼ 0.005) were significantly more common among patients with early mortality. Conclusion: Melioidosis is a devastating illness with a high rate of mortality occurring within 48 hours of presentation. Melioidosis that presents with CAP is the most severe form of the disease and is associated with greatly increased early mortality.
Introduction
Melioidosis is an endemic disease of Southeast Asia and northern Australia. With increasing worldwide travel, melioidosis has emerged as a global problem. 1 Infection usually occurs after percutaneous inoculation or inhalation of Burkholderia pseudomallei, which is present in the soil and surface water in endemic regions. 2 The first case of melioidosis in Taiwan was reported in 1985, 3 and sporadic cases have been reported thereafter. An outbreak of melioidosis occurred from July 2005 to September 2005 after southern Taiwan was struck by Typhoon Haitang, confirming that melioidosis is endemic to the island. 4, 5 Melioidosis is nicknamed "the great mimicker" because of its diverse clinical manifestations. 6, 7 Melioidosis clinically can be asymptomatic, latent, chronically localized, or acutely septicemic. The acute septicemic form of melioidosis, in addition to being frequently found as community-acquired pneumonia (CAP) and/or fatal septicemia, may take the form of musculoskeletal infection, urogenital infection, skin infection, brain abscess, liver abscess, and splenic abscess; these forms have all been reported in the literature and simulate a wide variety of diseases. 1, 2, 8 The mortality rate in patients with acute melioidosis is high if the infection is not promptly diagnosed and treated with timely and effective antibiotic therapy. 8e12 The clinical manifestations of melioidosis have been well studied, but little is known about the disease's clinical features and outcomes among patients with melioidosis who are treated at an emergency department (ED). The objective of this study was to better understand the demographics and clinical characteristics of patients with melioidosis who are treated in the ED.
Methods

Patient selection
We searched our hospital's computerized microbiology database for candidate individuals with melioidosis, and these patients were included in this study. Candidates were patients from whom a culture grown from any specimen was positively identified as B pseudomallei. Culture specimens were obtained between January 2001 and December 2007, and only patients whose medical records showed that the culture specimen was obtained during their visit to the ED were included in the study. Patients who were not admitted to the hospital after visiting the ED were excluded from the study. This study was approved by the Institutional Review Board and the need for informed consent was waived.
Data collection and definitions
Data were retrieved by retrospective review of patient medical records including demographics, clinical manifestations, imaging findings, laboratory data, initial diagnoses made at the ED, antimicrobial treatments, and outcomes. Soil exposure was defined as contact with soil during either occupational or recreational activity such as gardening, farming, camping, or construction work. Excessive alcohol consumption was defined as more than two drinks (20 g) per day in women and more than three drinks (30 g) per day in men. 5 Shock on arrival was defined as a systolic blood pressure below 90 mmHg or a decrease of more than 30 mmHg in comparison with the patient's baseline systolic blood pressure detected at the ED, coupled with clinical evidence of peripheral hypoperfusion. Appropriate empiric antibiotic therapy at the ED was defined as the start of empiric antibiotic treatment, using imipenem, meropenem, ceftazidime, amoxicillinclavulanic acid, or trimethoprim-sulfamethoxazole, which might be potentially effective against B pseudomallei. Suboptimal antimicrobial therapies refers to the inadequate dosage of in vitro susceptible antibiotic agents. Early mortality was defined as death within 48 hours after presentation at the ED and before microbiologic confirmation. Pneumonia is the most common presentation of melioidosis, 8, 9 and the patients who were part of this study were divided into two groups based on their clinical presentation at the ED. The CAP group comprised patients who initially presented with fever, chills, cough, pleuritic chest pain, sputum production, and at least one opacity on chest radiography; the non-CAP group comprised patients who did not present with pneumonia-like symptoms.
Statistical analysis
Variables from the two groups were compared. A MannWhitney exact test was used to assess differences in the continuous variables, whereas the Fisher exact test was used to assess differences in dichotomous variables between the two groups. Variables with p values less than 0.1 by univariate analysis were separately entered into a multivariate logistic regression model to identify independent risk factors for early mortality in patients with melioidosis. Variables with two-tailed p values less than 0.05 in multiple logistic regression were considered statistically significant.
Results
One patient was admitted to the hospital from an orthopedic outpatient clinic because of scheduled surgery for a herniated intervertebral lumbar disc; excised necrotic tissue from this patient was cultured and B pseudomallei was isolated 8 days after the surgery; this patient was excluded from the study. A total of 25 patients (mean age, 54 years; 92% male) with melioidosis were included in the analysis; of these, 84% were found to have at least one underlying condition, and diabetes mellitus (in 68% of patients) was the most common disease. Of the four patients (16%) with soil exposure, two were farmers and two were construction workers. Sixteen of the patients (64%) with melioidosis came to the ED during the rainy season in Taiwan (between June and September). The overall mortality rate was 40%, and early death within 48 hours after presentation at the ED occurred in 24% of the patients. The demographic information on these patients is presented in Table 1 .
A descriptive analysis of the clinical characteristics of the patients is presented in Table 2 . The most common infection site for melioidosis was the lungs (52%), followed by the genitourinary tract (28%) and the joints (16%). Nine of the patients (36%) had more than one site of infection. Of the 25 patients who were included in the study, acute respiratory failure that required mechanical ventilatory support developed in 13 (52%), and 22 (88%) had bacteremia. Of the five patients (20%) who were in shock upon arrival, four died, which meant that the mortality rate for patients suffering from shock was 80%. The time lapse between the blood and nonblood sampling for culture and the availability of results indicating B pseudomallei infection ranged from 3 to 8 days and 3 to 7 days, respectively. Only two patients (8%) were empirically treated with amoxicillin-clavulanic acid but at a suboptimal dosage for the treatment of melioidosis, whereas others received inappropriate empiric antibiotic therapy. The shortage of general wards and intensive care units is a serious issue in medical centers in Taiwan; therefore, patients often have to receive treatment in the ED. The average ED stay ranged from 1 to 6 days. Patients with melioidosis exhibited variable presentations upon arrival at the ED (Table 2) . Overall, nine patients with melioidosis presented to the ED with CAP and in another four patients, in whom pneumonia was not initially present, CAP developed at a later date. Pulmonary tuberculosis, endophthalmitis (occurring 3 days after arriving at the ED), nephrotic syndrome (occurring 3 days after arriving at the ED), and fever of unknown origin (occurring 4 days after arriving at the ED) were initially diagnosed in these four patients. A comparison of the clinical presentation on arrival at the ED between the initial CAP and non-CAP groups revealed that patients in the CAP group had a significantly higher frequency of band-form leukocytes ( p ¼ 0.012), higher levels of C-reactive protein (CRP) ( p ¼ 0.004), higher serum creatinine levels ( p ¼ 0.038), and a higher frequency of shock on arrival (56% vs. 0; p ¼ 0.002). Poor outcomes were also found among the patients in the CAP group, including a higher early mortality rate (56% vs. 6%; p ¼ 0.012) and a higher total mortality rate (78% vs. 19%; p ¼ 0.009), indicating that melioidosis pneumonia is the most severe form of the disease and this form of melioidosis is associated with a tendency toward increased early mortality.
There were six early deaths (60% of all mortalities) in our study. Of these six patients, chief complaints were fever in five and dyspnea in four. Four of these patients were treated at the ED during the rainy season in Taiwan. Shock upon arrival was present in four patients, and a rapid progression to pneumonia occurred in five patients. Laboratory studies revealed elevated CRP levels in four patients and band-form leukocytes in five patients. The survival time was less than 24 hours for three patients and between 24 and 48 hours for another three patients.
A comparison of the clinical variables between the early and nonearly mortality groups is shown in Table 3 . There were significant differences between these two groups, with a higher proportion having band-form leukocytes ( p ¼ 0.001), a higher level of serum creatinine ( p ¼ 0.037), a higher frequency of initial presentation with CAP (83.3% vs. 21.1%; p ¼ 0.012), and a higher likelihood of shock on arrival at the ED (66.7% vs. 5.3%; p ¼ 0.005). Multivariate logistic regression revealed that shock on arrival at the ED was an independent risk factor for early mortality among patients with melioidosis (odds ratio ¼ 36.0, 95% confidence interval ¼ 2.6e501.3; p ¼ 0.008).
Discussion
The reported in-hospital mortality rates for melioidosis range in the literature from 19% to 68%. 2, 8 In our series, the overall mortality rate was 40%, and death within 48 hours after presentation to the ED occurred in 24% of patients, indicating that melioidosis is a highly lethal infectious disease. However, standard clinical diagnostic criteria for this infectious disease have not yet been established for first-line physicians. Previous studies have indicated that the variation in the clinical presentation and the severity of the melioidosis may be due to one or more of the following three factors: variation in bacterial strain causing the infection including the presence or absence of virulence factors, variation in the patient's immune response, and variation in the mode of acquisition. 2 The prompt diagnosis of melioidosis is a great challenge to ED physicians because of the disease's diverse clinical presentations, a lack of clinical awareness, and delays in obtaining bacteriologic identification that can result in inappropriate empiric antimicrobial selection and may place patients at a greater risk for mortality. The isolation of B pseudomallei from body fluids remains the gold standard for the diagnosis of melioidosis. In our study, the mean duration of time that lapsed before a culture confirming B pseudomallei was obtained was 5 days (range, 3 to 8 days), and 60% of the deaths in this study occurred before a confirmed culture was available. Gram staining and other histopathologic stains are not specific for this organism. 13 A rapid and targeted microbiologic work-up, including techniques such as direct microscopy with direct immunofluorescence 14 and urinary antigen enzyme-linked immunosorbent assays, 15 might allow a rapid provisional diagnosis to be made. Although many of these rapid tests have been developed, few have been extensively tested in the field. It needs to be noted that our data, which include results showing that 80% of the total number of patients who died had lung infections, 70% initially presented with CAP on arrival at the ED, and that patients in whom mortality occurs within 48 hours have a greater chance of presenting with CAP at the ED compared with patients in whom early mortality does not occur ( p ¼ 0.012), suggest that melioidosis pneumonia is the most severe form of the disease and is associated with increased early mortality. The other deaths in our series occurred on the 9 th , 15 th , 16 th , and 47 th day after presentation at the ED and after culture results had confirmed melioidosis. Accordingly, it is important for ED physicians to differentiate between CAP and melioidosis pneumonia to start timely and effective antibiotic therapy. Our previous matched care-control study comparing patients with melioidosis pneumonia and those with nonmelioid CAP showed that visiting the ED during the rainy season, poor control of glucose levels, and arriving in the ED in shock were independent risk factors for patients with CAP caused by B pseudomallei. 16 Currie and Jacups 17 also indicated that heavy rainfall in the 14 days before admission was an independent risk factor for pneumonia, septic shock, and death in patients with melioidosis. It is postulated that heavy rainfall with strong winds brings buried B pseudomallei isolates to the soil surface; thereafter, they are more likely to be inhaled at high concentrations causing pneumonic melioidosis; this may result in the increased severity associated with septic shock and early mortality. Furthermore, according to the review of Cheng et al., 2 patients with diabetes mellitus in particular have a higher incidence of melioidosis; up to 60% of patients with melioidosis in this study had preexisting or newly diagnosed type 2 diabetes. Other reported risk factors in studies with a large series of patients with melioidosis include excessive alcohol intake, chronic renal failure, soil/water exposure, and chronic lung disease. 2 It should be noted that liver cirrhosis was the third leading underlying condition in our study. This finding has not been reported in previous studies, but needs to be taken into consideration as a risk factor for early diagnosis of melioidosis in Taiwan. In addition, we found that 36% of the patients in our series had more than one metastatic infection site; in this context, previous reports have suggested that melioidosis should be considered as a differential diagnosis for patients with fever and multiple metastatic infection sites. 8, 11 It is necessary to remind ED physicians that melioidosis should always be considered when a patient presents with rapidly progressing pneumonia in the presence of underlying risk factors and/or multiorgan involvement, especially after heavy rainfall.
Antimicrobial agents that are active against B pseudomallei include imipenem, meropenem, ceftazidime, and amoxicillinclavulanic acid. Previous reports have revealed that inappropriate empiric antibiotic therapy is an independent risk factor for mortality in community-acquired, as well as nosocomialacquired, bacteremia. 18, 19 In our study, all 23 patients received inappropriate empiric antibiotics or appropriate empirical antibiotics at a suboptimal dosage (2 patients) before a positive culture of B pseudomallei was confirmed, which suggests that ED physicians were unaware of melioidosis. This finding highlights the importance of early diagnosis, especially for the most severe forms of melioidosis seen in this study. Two patients received appropriate empiric antibiotics before a positive culture of B pseudomallei was confirmed, but the clinical conditions of these two patients deteriorated rapidly, and they died within 24 hours. Inadequate dosage (1200 mg every 8 hours) of amoxicillin-clavulanic acid might be one of the reasons for the treatment failure in these two patients. An increased frequency of treatment (amoxicillin-clavulanic acid 20/4 mg/kg, intravenous, every 4 hours) to ensure adequate levels of clavulanic acid in the bloodstream when treating melioidosis has been suggested when melioidosis was suspected in the ED. 20 To the best of our knowledge, few studies have specifically described the clinical course of individuals presenting with melioidosis at the ED. We found that 6 of the 10 deaths (60%) due to melioidosis occurred within 48 hours of arrival at ED. Of these six patients, five had fulminate pneumonia and three died within 24 hours of arrival at the ED. All five patients with fulminate pneumonia were initially treated with respiratory tract quinolones, a b-lactam/b-lactamase inhibitor, or a nonanti-Pseudomonas-extended-range cephalosporin, which are the preferred antimicrobial regimens for CAP according to the current treatment guidelines developed by the Infectious Diseases Society of America and the American Thoracic Society. 21 However, we found that the early mortality rate of our patients with acute melioidosis pneumonia was 56%, which is much higher than that observed for both patients with CAP in the ED (2.5%) 22 and patients with nonmelioid CAP (18.3%) in our previous study. 16 The current recommended antimicrobial agents and dosages for CAP are not active against B pseudomallei in vitro.
2 A specific guideline for CAP that is caused by B pseudomallei is needed in addition to a locally adapted guideline for CAP treatment in an endemic area. From the current study, we conclude that shock at the time of ED arrival is an ominous sign of early mortality in patients with melioidosis and that this is not specific to any other form of septic shock. However, our study highlights the fact that the early mortality rate of patients with acute melioidosis pneumonia is much higher than that observed in patients with CAP in the ED. It is necessary to remind ED physicians that melioidosis is a devastating illness, with a high rate of mortality within 48 hours after presentation at the ED, and that early recognition and the choice of effective antibiotics is important.
There were several limitations in our study. First, one of the shortcomings of our study is that it is a single-institution study that described the hospital course of a small number of individuals in the ED. Second, the retrospective nature of the study inevitably results in incomplete information collection regarding the time of diagnosis and the time of initiation of effective antimicrobial therapy in these patients. Thus, the information regarding the appropriate timing of initiating effective antimicrobial therapy for melioidosis in this study is scarce. Moreover, because all of the patients received inappropriate or inadequate empiric antibiotic therapy in this study, it is impossible to evaluate whether inappropriate empirical antibiotic therapy is an independent risk factor for mortality using the logistic regression model.
In conclusion, melioidosis is a devastating illness with a high rate of mortality occurring within 48 hours after presentation at the ED. Melioidosis with rapidly progressing pneumonia, which is the most severe form of the disease, is associated with increased early mortality. Melioidosis should be considered as a differential diagnosis for any patient with rapidly deteriorating CAP and/or sepsis with an acute fulminating course who presents to an ED in an endemic area, especially after a typhoon or heavy rain.
